{'Year': '2021', 'Month': 'Oct'}
Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation.
Combination treatments, targeting multiple disease processes, benefit subjects with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). However, predicting treatment response and exacerbation risk remain challenging.